[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634234":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":27,"locations":33,"responsibleParty":49,"collaborators":23,"id":53,"slug":23,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":23,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":23,"enrollmentInfo":61,"targetDuration":23,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":23,"overallStatus":35,"whyStopped":23,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"QIPB group","EXPERIMENTAL","Patients will receive ipsilateral Quadro-iliac plane block (QIPB) using 20ml of bupivacaine 0.25%.",[13],"Other: Quadro-iliac plane block",{"label":15,"type":10,"description":16,"interventionNames":17},"ESPB group","Patients will receive ipsilateral erector spinae plane block (ESPB) using 20ml of bupivacaine 0.25%.",[18],"Other: Erector spinae plane block",[20,24],{"type":6,"name":21,"description":11,"armGroupLabels":22,"otherNames":23},"Quadro-iliac plane block",[9],null,{"type":6,"name":25,"description":16,"armGroupLabels":26,"otherNames":23},"Erector spinae plane block",[15],[28],{"name":29,"role":30,"phone":31,"phoneExt":23,"email":32},"Mohammed S Elsharkawy, MD","CONTACT","00201148207870","mselsharkawy@med.tanta.edu.eg",[34],{"facility":5,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Tanta","El-Gharbia","31527","Egypt","EG",{"type":42,"coordinates":43},"Point",[44,45],31.00192,30.78847,{"lat":45,"lon":44},[48],{"name":29,"role":30,"phone":31,"phoneExt":23,"email":32},{"type":50,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"PRINCIPAL_INVESTIGATOR","Mohammed Said ElSharkawy","Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.","100634234",false,"NCT07537036","Analgesic Efficacy of Quadro-Iliac Plane Block Versus Erector Spinae Plane in Total Hip Arthroplasty","Analgesic Efficacy of Quadro-Iliac Plane Block Versus Erector Spinae Plane in Total Hip Arthroplasty: A Randomized Non-Inferiority Trial","Inclusion Criteria:\n\n* Age ≥ 18 years.\n* Both sexes.\n* American Society of Anesthesiology (ASA) physical status I-III.\n* Undergoing total hip arthroplasty (THA) under spinal anesthesia.\n\nExclusion Criteria:\n\n* History of allergies to local anesthetics.\n* Opioid dependency.\n* Body mass index (BMI) \\> 35 kg\u002Fm2.\n* Cognitive impairment.\n* Bleeding or coagulation disorders.\n* Psychiatric and neurological disorder.\n* Local infection at the site of injection.\n* Severe heart, lung, liver, and renal dysfunction.\n* Emergency surgery.","ALL","18 Years",{"count":62,"type":63},76,"ESTIMATED","INTERVENTIONAL",[66],"NA","This study aims to compare the Quadro-Iliac Plane Block versus Erector Spinae Plane Block after total hip arthroplasty.",[69,70,71,72],"Analgesic Efficacy","Quadro-Iliac Plane Block","Erector Spinae Plane Block","Total Hip Arthroplasty","2026-06-22",{"date":75,"type":76},"2026-06-23","ACTUAL",{"date":78,"type":76},"2026-04-18",{"date":80,"type":63},"2026-11-30",{"name":5,"class":6},1]